Biotech SF
San Francisco Bay Area biotech stories.
Monday, December 20, 2010
Gilead to buy Palo Alto's Arresto, IPF antibody drug maker, for $225M
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment